Eli Lilly adds to argument against fine, asks Brazilian regulator to review finding of repeated infringement
Eli Lilly do Brasil has filed a new appeal with the Brazilian competition authority arguing against the 36.6 million reais ($11.8 million) fine imposed on the company for launching spurious court...To view the full article, register now.
Already a subscriber? Click here to view full article